The application of radiogenomics in oncology has great prospects in precision medicine.
Radiogenomics combines large volumes of radiomic features from medical digital images …

Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

Advances in radiotherapy technologies have enabled more precise target guidance,
improved treatment verification, and greater control and versatility in radiation delivery …

Soft‐tissue sarcomas (STS) represent a group of rare and heterogeneous tumors associated
with several challenges, including incorrect or late diagnosis, the lack of clinical expertise …

Increasing evidence suggests that besides mutational and molecular alterations, the
immune component of the tumor microenvironment also substantially impacts tumor …

The recent, rapid advances in immuno-oncology have revolutionized cancer treatment and
spurred further research into tumor biology. Yet, cancer patients respond variably to …

Objectives The tumor microenvironment (TME) consists of cellular and noncellular
components which enable the tumor to interact with its surroundings and plays an important …

Simple Summary Prostate cancer (PCa) is one of the most frequent malignancies diagnosed
in men and its prognosis depends on the stage at diagnosis. Molecular imaging, namely …

Simple Summary The introduction of immune checkpoint inhibitors has represented a
milestone in cancer treatment. Despite PD-L1 expression being the standard biomarker …

Background Finding a noninvasive radiomic surrogate of tumor immune features could help
identify patients more likely to respond to novel immune checkpoint inhibitors. Particularly …